FDA Spending Bill Goes To House Panel At Lower Level Than Senate
This article was originally published in The Pink Sheet Daily
Executive Summary
A House appropriations subcommittee on June 6 will mark up a bill that would give FDA $44 million less to spend in Fiscal 2013 than a measure produced by the Senate Appropriations Committee, indicating a conference committee will be the final arbiter of agency funding.
You may also be interested in...
Increased FDA China Inspections Backed By House Panel, While Purse Strings Pulled Still Tighter
Funds for the Reagan-Udall Foundation must come from the FDA commissioner’s office account, under successful amendment from Rep. DeLauro.
FDA Largely Ignored At Appropriations Subcommittee Mark-Up
Rep. DeLauro proposes only amendment, which did not affect FDA and was defeated, but also warns FDA cuts could endanger Americans’ health.
House Approps Bill Would "Harden" Science Requirements For FDA Rules, Guidance
Provision meant to protect ranchers/farmers could unleash Pandora's box of impediments to regulations, guidance; panel debates Avastin.